Arcturus Therapeutics Holdings Inc (NQ:ARCT)

13.53 +0.50 (+3.84%)

Delayed Quote Updated: 1:26 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Arcturus Therapeutics Holdings Inc

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

March 29, 2023

Via Benzinga

Arcturus Therapeutics Ltd. (NASDAQ: ARCT) Leading the Way in Wednesday Trading Based on Percentage Gain

March 29, 2023

Via Investor Brand Network

Why Kodiak Sciences Shares Are Trading Higher By 18%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

March 29, 2023

Gainers LogicMark, Inc. (NASDAQ: LGMK) shares jumped 76.1% to $0.2466 after the company announced financial results for the year ended 2022. The company reported FY22 revenue of $11.9 million.

Via Benzinga

Why Arcturus Therapeutics Stock Is Soaring Today ↗

March 29, 2023

Investors liked what they heard in its Q4 update.

Via The Motley Fool

Arcturus Therapeutics's Return On Capital Employed Insights ↗

March 29, 2023

Via Benzinga

A Preview Of Arcturus Therapeutics's Earnings ↗

March 27, 2023

Via Benzinga

Arcturus Therapeutics's Return On Capital Employed Overview ↗

December 15, 2022

Via Benzinga

Nasdaq Rises 1%; US Pending Home Sales Increase In February ↗

March 29, 2023

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 100 points on Wednesday. The Dow traded up 0.58% to 32,580.89 while the NASDAQ rose 1.09% to 11,843.85. The S&P...

Via Benzinga

Arcturus Therapeutics Stock Is Rising Wednesday: What's Going On? ↗

March 29, 2023

Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) shares are trading higher Wednesday after the company reported strong fourth-quarter results and provided an update on pipeline progress.

Via Benzinga

US Stocks Open Higher, Dow Jumps Over 200 Points ↗

March 29, 2023

U.S. stocks traded higher this morning, with the Dow Jones gaining over 200 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.72% to 32,628.42 while the NASDAQ rose 1.33%...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

March 29, 2023

Via Benzinga

Why Shift Technologies Shares Are Trading Lower By 15%; Here Are 20 Stocks Moving Premarket ↗

March 29, 2023

Gainers LogicMark, Inc. (NASDAQ: LGMK) shares rose 36.7% to $0.1914 in pre-market trading after the company reported strong revenue and margin growth for the year ended 2022.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

March 29, 2023

We're starting off Wednesday with a breakdown of the biggest pre-market stock movers traders will want to keep an eye on!

Via InvestorPlace

Cal-Maine Foods, Lululemon Athletica And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session ↗

March 29, 2023

U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.

Via Benzinga

Why Arcturus Therapeutics Shares Are Moving Higher After Hours ↗

March 28, 2023

Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) shares are booming in Tuesday's after-hours session after the company reported fourth-quarter results and provided an update on

Via Benzinga

Arcturus Therapeutics Announces Fourth Quarter 2022 Financial Update and Pipeline Progress

March 28, 2023

From Arcturus Therapeutics Holdings Inc.

Via Business Wire

Arcturus Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Corporate Update on March 28, 2023

March 07, 2023

From Arcturus Therapeutics Holdings Inc.

Via Business Wire

Arcturus Therapeutics to Attend Upcoming Investor Conferences

February 06, 2023

From Arcturus Therapeutics Holdings Inc.

Via Business Wire

Arcturus Therapeutics Announces Clinical Trial Application for ARCT-032 Received Approval to Proceed into First-in-Human Studies to Treat Cystic Fibrosis

January 31, 2023

From Arcturus Therapeutics Holdings Inc.

Via Business Wire

Arcturus Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference

December 19, 2022

From Arcturus Therapeutics Holdings Inc.

Via Business Wire

Arcturus Appoints John Markels, Ph.D. to its Board of Directors

December 13, 2022

From Arcturus Therapeutics Holdings Inc.

Via Business Wire

Why CSL Ltd Stock Could Be Worth a Look

December 03, 2022

FDA approval of costly--but worthwhile--drug leads the momentum that could make CSL Ltd an equally worthwhile investment.

Via MarketBeat

Benzinga's Top Ratings Upgrades, Downgrades For November 10, 2022 ↗

November 10, 2022

Upgrades

Via Benzinga

Arcturus Therapeutics Announces Third Quarter 2022 Financial Update and Pipeline Progress

November 09, 2022

From Arcturus Therapeutics Holdings Inc.

Via Business Wire

Arcturus Therapeutics to Present at the Following Investor Conferences in November

November 07, 2022

From Arcturus Therapeutics Holdings Inc.

Via Business Wire

United Therapeutics, Super Micro Computer, Novo Nordisk And Other Big Gainers From Wednesday ↗

November 03, 2022

U.S. stocks closed lower on Wednesday, with the Dow Jones dropping more than 500 points. Here is the list of some big stocks recording gains in the previous session.

Via Benzinga

Why Tupperware Brands Shares Dipped Around 42%; Here Are 89 Biggest Movers From Yesterday ↗

November 03, 2022

Gainers Starry Group Holdings, Inc. (NYSE: STRY) rose 55.6% to close at $0.28 on Wednesday after reporting Q3 results.

Via Benzinga

Why Benefitfocus Shares Are Trading Higher By Around 48%? Here Are 64 Stocks Moving In Wednesday's Mid-Day Session ↗

November 02, 2022

Gainers Starry Group Holdings, Inc. (NYSE: STRY) gained 56% to $0.2808 after reporting Q3 results.

Via Benzinga

Why Is Rogers Corporation (ROG) Stock Down 44% Today? ↗

November 02, 2022

Rogers Corporation (ROG) stock is falling hard on Wednesday following confirmation that DuPont (DD) no longer plans to acquire the company.

Via InvestorPlace

Why Is Benefitfocus (BNFT) Stock Up 48% Today? ↗

November 02, 2022

Benefitfocus (BNFT) stock is rocketing higher on Wednesday as investors react to a $570 million acquisition deal with Voya Financial (VOYA).

Via InvestorPlace

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.